speb/financial-data huggingface dataset:
REPX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 85397000.00
REPX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 160840000.00
REPX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 85397000.00
REPX income_statement (annual, 2025-12-31) — Net Interest Income: -31364000.00
REPX income_statement (quarterly, 2025-12-31) — Net Interest Income: -7926000.00
REPX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -25000000.00
REPX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -120000000.00
REPX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -25000000.00
REPX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -120000000.00
REPX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -31364000.00
REPX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -7926000.00
REPX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -432000.00
REPX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -189000.00
REPX cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1196000.00
REPX cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
REPX balance_sheet (annual, 2025-12-31) — Net PPE: 1022850000.00
REPX balance_sheet (quarterly, 2025-12-31) — Net PPE: 1022850000.00
REPX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -11121000.00
REPX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 67935000.00
REPX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 634242000.00
REPX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 634242000.00
REPX balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 4064000.00
REPX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 4064000.00
REPX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 86119000.00
REPX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 86119000.00
REPX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 86119000.00
REPX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 86119000.00
REPX balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 4846000.00
REPX balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 4846000.00
REPX income_statement (annual, 2025-12-31) — Normalized EBITDA: 230957000.00
REPX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 54241000.00
REPX income_statement (annual, 2025-12-31) — Normalized Income: 83888510.00
REPX income_statement (quarterly, 2025-12-31) — Normalized Income: 15170380.75
REPX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 212539000.00
REPX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 64868000.00
REPX cash_flow (annual, 2025-12-31) — Operating Gains Losses: -90133000.00
REPX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -84351000.00
REPX income_statement (annual, 2025-12-31) — Operating Income: 141276000.00
REPX income_statement (quarterly, 2025-12-31) — Operating Income: 28221000.00
REPX income_statement (annual, 2025-12-31) — Operating Revenue: 391980000.00
REPX income_statement (quarterly, 2025-12-31) — Operating Revenue: 97277000.00
REPX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 21718800.00
REPX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 21718800.00
REPX balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 20000000.00
REPX balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 20000000.00
REPX balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 7500000.00
REPX balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 7500000.00
REPX income_statement (annual, 2025-12-31) — Other Gand A: 31472000.00
REPX income_statement (quarterly, 2025-12-31) — Other Gand A: 7913000.00
REPX income_statement (annual, 2025-12-31) — Other Income Expense: 99051000.00
REPX income_statement (quarterly, 2025-12-31) — Other Income Expense: 90465000.00
REPX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 4770000.00
REPX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1208000.00
REPX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 2746000.00
REPX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 2746000.00
REPX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 4768000.00
REPX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 4768000.00
REPX income_statement (annual, 2025-12-31) — Other Operating Expenses: 361000.00
REPX income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 88000.00
REPX balance_sheet (annual, 2025-12-31) — Other Payable: 59606000.00
REPX balance_sheet (quarterly, 2025-12-31) — Other Payable: 59606000.00
REPX balance_sheet (annual, 2025-12-31) — Other Properties: 3323000.00
REPX balance_sheet (quarterly, 2025-12-31) — Other Properties: 3323000.00
REPX balance_sheet (annual, 2025-12-31) — Other Receivables: 4318000.00
REPX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 4318000.00
REPX balance_sheet (annual, 2025-12-31) — Payables: 92141000.00
REPX balance_sheet (quarterly, 2025-12-31) — Payables: 92141000.00
REPX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 117394000.00
REPX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 117394000.00
REPX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
REPX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
REPX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 7763000.00
REPX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 7763000.00
REPX income_statement (annual, 2025-12-31) — Pretax Income: 208963000.00
REPX income_statement (quarterly, 2025-12-31) — Pretax Income: 110760000.00
REPX cash_flow (annual, 2025-12-31) — Purchase Of Business: -133452000.00
REPX cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -875000.00
REPX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -131325000.00
REPX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -52269000.00
REPX balance_sheet (annual, 2025-12-31) — Receivables: 41045000.00
REPX balance_sheet (quarterly, 2025-12-31) — Receivables: 41045000.00
REPX balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -601000.00
REPX balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -601000.00
REPX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 209741000.00
REPX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 58667000.00
REPX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 93183000.00
REPX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 27268000.00
REPX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -180000000.00
REPX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -120000000.00
REPX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -3248000.00
REPX cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -1824000.00
REPX income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 5176000.00
REPX income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 453000.00
REPX balance_sheet (annual, 2025-12-31) — Retained Earnings: 327560000.00
REPX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 327560000.00
REPX income_statement (annual, 2025-12-31) — Salaries And Wages: 9130000.00
REPX income_statement (quarterly, 2025-12-31) — Salaries And Wages: 2388000.00
REPX cash_flow (annual, 2025-12-31) — Sale Of PPE: 120204000.00
REPX income_statement (annual, 2025-12-31) — Selling General And Administration: 40602000.00
REPX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 10301000.00
REPX balance_sheet (annual, 2025-12-31) — Share Issued: 21718800.00
REPX balance_sheet (quarterly, 2025-12-31) — Share Issued: 21718800.00
REPX income_statement (annual, 2025-12-31) — Special Income Charges: 63678000.00
REPX income_statement (quarterly, 2025-12-31) — Special Income Charges: 69615000.00
REPX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 9130000.00
REPX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2388000.00
REPX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 634242000.00
REPX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 634242000.00
REPX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 634242000.00
REPX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 634242000.00
REPX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 22985510.00
REPX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 20857380.75
REPX income_statement (annual, 2025-12-31) — Tax Provision: 48123000.00
REPX income_statement (quarterly, 2025-12-31) — Tax Provision: 25363000.00
REPX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.23
REPX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
REPX balance_sheet (annual, 2025-12-31) — Total Assets: 1169578000.00
REPX balance_sheet (quarterly, 2025-12-31) — Total Assets: 1169578000.00
REPX balance_sheet (annual, 2025-12-31) — Total Capitalization: 862097000.00
REPX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 862097000.00
REPX balance_sheet (annual, 2025-12-31) — Total Debt: 255015000.00
REPX balance_sheet (quarterly, 2025-12-31) — Total Debt: 255015000.00
REPX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 634242000.00
REPX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 634242000.00
REPX income_statement (annual, 2025-12-31) — Total Expenses: 250704000.00
REPX income_statement (quarterly, 2025-12-31) — Total Expenses: 69056000.00
REPX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 535336000.00
REPX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 535336000.00
REPX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1075811000.00
REPX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1075811000.00
REPX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 378831000.00
REPX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 378831000.00
REPX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 133279000.00
REPX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 26161000.00
REPX income_statement (annual, 2025-12-31) — Total Other Finance Cost: 3292000.00
REPX income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 828000.00
REPX balance_sheet (annual, 2025-12-31) — Total Tax Payable: 27452000.00
REPX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 27452000.00
REPX income_statement (annual, 2025-12-31) — Total Unusual Items: 99937000.00
REPX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 91084000.00
REPX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 99937000.00
REPX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 91084000.00
REPX balance_sheet (annual, 2025-12-31) — Working Capital: -62738000.00
REPX balance_sheet (quarterly, 2025-12-31) — Working Capital: -62738000.00
REPX income_statement (quarterly, 2026-03-31) — +Operating Expense: 11388000.00
REPX income_statement (quarterly, 2026-03-31) — +Total Revenue: 113881000.00
REPX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 22716000.00
REPX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 50196000.00
REPX balance_sheet (quarterly, 2026-03-31) — Accrued Interest Receivable: 7031000.00
REPX balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -367406000.00
REPX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 304900000.00
REPX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 20869000.00
REPX income_statement (quarterly, 2026-03-31) — Basic EPS: -3.38
REPX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 17889000.00
REPX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -33903000.00
REPX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 7561000.00
REPX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 22000.00
REPX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 15809000.00
REPX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 15809000.00
REPX cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -8360000.00
REPX balance_sheet (quarterly, 2026-03-31) — Cash Financial: 15809000.00
REPX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -20447000.00
REPX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -28809000.00
REPX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 47176000.00
REPX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 10727000.00
REPX cash_flow (quarterly, 2026-03-31) — Change In Inventory: -1087000.00
REPX cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 502000.00
REPX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 2468000.00
REPX cash_flow (quarterly, 2026-03-31) — Change In Payable: 8307000.00
REPX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 8307000.00
REPX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -627000.00
REPX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -17071000.00
REPX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -7508000.00
REPX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -17071000.00
REPX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2080000.00
REPX balance_sheet (quarterly, 2026-03-31) — Common Stock: 22000.00
REPX cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -8360000.00
REPX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 553440000.00
REPX cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -4061000.00
REPX balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 661000.00
REPX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 58823000.00
REPX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 35514000.00
REPX balance_sheet (quarterly, 2026-03-31) — Current Assets: 83067000.00
REPX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 7561000.00
REPX balance_sheet (quarterly, 2026-03-31) — Current Debt: 20000000.00
REPX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 27561000.00
REPX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 16532000.00
REPX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 263655000.00
REPX cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -23308000.00
REPX cash_flow (quarterly, 2026-03-31) — Deferred Tax: -23308000.00
REPX cash_flow (quarterly, 2026-03-31) — Depletion: 25720000.00
REPX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 25720000.00
REPX balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 14587000.00
REPX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 20869000.00
REPX income_statement (quarterly, 2026-03-31) — Diluted EPS: -3.38
REPX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -70434000.00
REPX cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 1487000.00
REPX income_statement (quarterly, 2026-03-31) — EBIT: -87062000.00
REPX income_statement (quarterly, 2026-03-31) — EBITDA: -61342000.00
REPX income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -368000.00
REPX cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 368000.00
REPX cash_flow (quarterly, 2026-03-31) — End Cash Position: 15809000.00
REPX balance_sheet (quarterly, 2026-03-31) — Financial Assets: 1388000.00
REPX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -20447000.00
REPX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 13273000.00
REPX cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 115245000.00
REPX cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: 2697000.00
REPX cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 913000.00
REPX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -126970000.00
REPX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 10421000.00
REPX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1412372000.00
REPX income_statement (quarterly, 2026-03-31) — Gross Profit: 55058000.00
REPX balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 0.00
REPX cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 10000000.00
REPX balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 13196000.00
REPX income_statement (quarterly, 2026-03-31) — Interest Expense: 5660000.00
REPX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 5660000.00
REPX income_statement (quarterly, 2026-03-31) — Interest Income: 175000.00
REPX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 175000.00
REPX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 5469000.00
REPX balance_sheet (quarterly, 2026-03-31) — Inventory: 7919000.00
REPX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 794115000.00
REPX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -28809000.00
REPX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 39820000.00
REPX cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 8000000.00
REPX balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 7983000.00
REPX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 220675000.00
REPX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 220675000.00
REPX cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 8000000.00
REPX cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -16000000.00
REPX balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 39820000.00
REPX balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 59426000.00
REPX balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 18526000.00
REPX cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -4000000.00
REPX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -4061000.00
REPX balance_sheet (quarterly, 2026-03-31) — Net Debt: 224866000.00
REPX income_statement (quarterly, 2026-03-31) — Net Income: -70434000.00
REPX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -70434000.00
REPX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -70434000.00
REPX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -70434000.00
REPX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -70434000.00
REPX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -70434000.00
REPX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -70434000.00
REPX income_statement (quarterly, 2026-03-31) — Net Interest Income: -6357000.00
REPX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 7607000.00
REPX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -8000000.00
REPX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -8000000.00
REPX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -6357000.00
REPX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -26000.00
REPX balance_sheet (quarterly, 2026-03-31) — Net PPE: 1044966000.00
REPX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -33903000.00
REPX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 553440000.00
REPX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 3751000.00
REPX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 62811000.00
REPX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 62811000.00
REPX balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 4343000.00
REPX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 68325000.00
REPX income_statement (quarterly, 2026-03-31) — Normalized Income: 28112920.00
REPX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 47176000.00
REPX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 119223000.00
REPX income_statement (quarterly, 2026-03-31) — Operating Income: 43670000.00
REPX income_statement (quarterly, 2026-03-31) — Operating Revenue: 113881000.00
REPX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 21567428.00
REPX balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 20000000.00
REPX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 89648000.00
REPX income_statement (quarterly, 2026-03-31) — Other Gand A: 8120000.00
REPX income_statement (quarterly, 2026-03-31) — Other Income Expense: -130035000.00
REPX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1182000.00
REPX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 2746000.00
REPX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 5487000.00
REPX income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 967000.00
REPX balance_sheet (quarterly, 2026-03-31) — Other Payable: 57186000.00
REPX balance_sheet (quarterly, 2026-03-31) — Other Properties: 3353000.00
REPX balance_sheet (quarterly, 2026-03-31) — Other Receivables: 16000.00
REPX balance_sheet (quarterly, 2026-03-31) — Payables: 94400000.00
REPX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 129914000.00
REPX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
REPX balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 2710000.00
REPX income_statement (quarterly, 2026-03-31) — Pretax Income: -92722000.00
REPX cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -4000000.00
REPX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -33903000.00
REPX balance_sheet (quarterly, 2026-03-31) — Receivables: 56629000.00
REPX balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -614000.00
REPX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 58823000.00
REPX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 25720000.00
REPX cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -16000000.00
REPX cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -4061000.00
REPX income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 2697000.00
REPX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 248518000.00
REPX income_statement (quarterly, 2026-03-31) — Salaries And Wages: 2301000.00
REPX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 7607000.00
REPX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 10421000.00
REPX balance_sheet (quarterly, 2026-03-31) — Share Issued: 21567428.00
REPX income_statement (quarterly, 2026-03-31) — Special Income Charges: -2697000.00
REPX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2301000.00
REPX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 553440000.00
REPX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 553440000.00
REPX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -31120080.00
REPX income_statement (quarterly, 2026-03-31) — Tax Provision: -22288000.00
REPX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
REPX balance_sheet (quarterly, 2026-03-31) — Total Assets: 1180081000.00
REPX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 774115000.00
REPX balance_sheet (quarterly, 2026-03-31) — Total Debt: 248236000.00
REPX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 553440000.00
REPX income_statement (quarterly, 2026-03-31) — Total Expenses: 70211000.00
REPX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 626641000.00
REPX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1097014000.00
REPX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 362986000.00
REPX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 43670000.00
REPX income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 872000.00
REPX balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 14498000.00
REPX income_statement (quarterly, 2026-03-31) — Total Unusual Items: -129667000.00
REPX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -129667000.00
REPX balance_sheet (quarterly, 2026-03-31) — Working Capital: -180588000.00
RERE cash_flow (annual, 2021-12-31) — Common Stock Issuance: 1488866000.00
RERE balance_sheet (annual, 2021-12-31) — Current Deferred Assets: 91245000.00
RERE balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Non Current: 0.00
RERE cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 110000.00
RERE cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 585000.00
RERE balance_sheet (annual, 2021-12-31) — Goodwill: 1803415000.00
RERE income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
RERE cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 2627098000.00
RERE cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
RERE cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
RERE cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
RERE cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
RERE cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -30203000.00
RERE cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 1138232000.00
RERE balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 103610000.00
RERE income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 508627000.00
RERE balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 0.00
RERE cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 1138232000.00
RERE cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
RERE cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
RERE income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
RERE income_statement (annual, 2021-12-31) — Total Unusual Items: 0.00
RERE income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 0.00
RERE income_statement (annual, 2022-12-31) — +Operating Expense: 3076542000.00
RERE income_statement (annual, 2022-12-31) — +Total Revenue: 9869424000.00
RERE balance_sheet (annual, 2022-12-31) — Accounts Payable: 73335000.00
RERE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 150621000.00
RERE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -166244000.00
RERE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 13131263000.00
RERE cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 2118374000.00
RERE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 127593000.00
RERE income_statement (annual, 2022-12-31) — Basic Average Shares: 246696076.00
RERE income_statement (annual, 2022-12-31) — Basic EPS: -10.01
RERE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1506642000.00
RERE cash_flow (annual, 2022-12-31) — Capital Expenditure: -61463000.00
RERE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 79949000.00
RERE balance_sheet (annual, 2022-12-31) — Capital Stock: 921000.00
RERE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1703626000.00
RERE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 2485856000.00
RERE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -186043000.00
RERE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -516683000.00
RERE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 881297000.00
RERE cash_flow (annual, 2022-12-31) — Change In Account Payable: 14468000.00
RERE cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 158158000.00
RERE cash_flow (annual, 2022-12-31) — Change In Inventory: 36412000.00
RERE cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 9789000.00
RERE cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -53109000.00
RERE cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -128421000.00
RERE cash_flow (annual, 2022-12-31) — Change In Payable: -58210000.00
RERE cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 99948000.00
RERE cash_flow (annual, 2022-12-31) — Change In Receivables: 630789000.00
RERE cash_flow (annual, 2022-12-31) — Change In Working Capital: 595408000.00
RERE cash_flow (annual, 2022-12-31) — Changes In Cash: 178571000.00
RERE balance_sheet (annual, 2022-12-31) — Common Stock: 921000.00
RERE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3881672000.00
RERE cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
RERE cash_flow (annual, 2022-12-31) — Common Stock Payments: -217920000.00
RERE balance_sheet (annual, 2022-12-31) — Construction In Progress: 7640000.00
RERE income_statement (annual, 2022-12-31) — Cost Of Revenue: 7596613000.00
RERE balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 173984000.00
RERE balance_sheet (annual, 2022-12-31) — Current Assets: 3890178000.00
RERE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 46426000.00
RERE balance_sheet (annual, 2022-12-31) — Current Debt: 123983000.00
RERE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 170409000.00
RERE balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 16659000.00
RERE balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 195369000.00
RERE balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 195369000.00
RERE balance_sheet (annual, 2022-12-31) — Current Liabilities: 1022248000.00
RERE cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 405408000.00
RERE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 405408000.00
RERE income_statement (annual, 2022-12-31) — Diluted Average Shares: 246696076.00
RERE income_statement (annual, 2022-12-31) — Diluted EPS: -10.01
RERE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -2467937000.00
RERE balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 115501000.00
RERE balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Non Current: 180000000.00
RERE balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 47604000.00
RERE income_statement (annual, 2022-12-31) — EBIT: -2567086000.00
RERE income_statement (annual, 2022-12-31) — EBITDA: -2161678000.00
RERE income_statement (annual, 2022-12-31) — Earnings From Equity Interest Net Of Tax: -6471000.00
RERE cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 6471000.00
RERE cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 18413000.00
RERE cash_flow (annual, 2022-12-31) — End Cash Position: 1703626000.00
RERE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -186043000.00
RERE cash_flow (annual, 2022-12-31) — Free Cash Flow: 819834000.00
RERE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
RERE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 1894000.00
RERE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -25708000.00
RERE income_statement (annual, 2022-12-31) — General And Administrative Expense: 230421000.00
RERE balance_sheet (annual, 2022-12-31) — Goodwill: 0.00
RERE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 544650000.00
RERE balance_sheet (annual, 2022-12-31) — Gross PPE: 284844000.00
RERE income_statement (annual, 2022-12-31) — Gross Profit: 2272811000.00
RERE income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 1819926000.00
RERE income_statement (annual, 2022-12-31) — Interest Expense: 6163000.00
RERE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 6163000.00
RERE income_statement (annual, 2022-12-31) — Interest Income: 17780000.00
RERE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 17780000.00
RERE cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 6163000.00
RERE balance_sheet (annual, 2022-12-31) — Inventory: 433467000.00
RERE balance_sheet (annual, 2022-12-31) — Invested Capital: 4005655000.00
RERE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -516683000.00
RERE balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 127593000.00
RERE balance_sheet (annual, 2022-12-31) — Investments And Advances: 219583000.00
RERE balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 42768000.00
RERE balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 49222000.00
RERE cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
RERE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 185983000.00
RERE balance_sheet (annual, 2022-12-31) — Leases: 124990000.00
RERE balance_sheet (annual, 2022-12-31) — Line Of Credit: 123983000.00
RERE balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 33523000.00
RERE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 33523000.00
RERE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
RERE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
RERE balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 91990000.00
RERE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 81723000.00
RERE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 29871000.00
RERE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -217920000.00
RERE cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -48624000.00
RERE income_statement (annual, 2022-12-31) — Net Income: -2467937000.00
RERE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -2467937000.00
RERE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -2467937000.00
RERE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -2467937000.00
RERE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -2467937000.00
RERE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -2467937000.00
RERE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -2467937000.00
RERE income_statement (annual, 2022-12-31) — Net Interest Income: 11617000.00
RERE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -483608000.00
RERE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 29013000.00
RERE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
RERE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 11617000.00
RERE cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -7000000.00
RERE balance_sheet (annual, 2022-12-31) — Net PPE: 118600000.00
RERE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -55946000.00
RERE cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
RERE cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 29013000.00
RERE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3337022000.00
RERE balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 180000000.00
RERE balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 111312000.00
RERE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 111312000.00
RERE income_statement (annual, 2022-12-31) — Normalized EBITDA: -341752000.00
RERE income_statement (annual, 2022-12-31) — Normalized Income: -726995788.40
RERE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 881297000.00
RERE cash_flow (annual, 2022-12-31) — Operating Gains Losses: -40259000.00
RERE income_statement (annual, 2022-12-31) — Operating Income: -803731000.00
RERE income_statement (annual, 2022-12-31) — Operating Revenue: 9869424000.00
RERE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 149216125.00
RERE balance_sheet (annual, 2022-12-31) — Other Current Assets: 52345000.00
RERE balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 129264000.00
RERE balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 174472000.00
RERE balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -25708000.00
RERE income_statement (annual, 2022-12-31) — Other Gand A: 230421000.00
RERE income_statement (annual, 2022-12-31) — Other Income Expense: -1781135000.00
RERE balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 544650000.00
RERE cash_flow (annual, 2022-12-31) — Other Non Cash Items: 53765000.00
RERE balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 95744000.00
RERE income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 38791000.00
RERE income_statement (annual, 2022-12-31) — Other Operating Expenses: 1082257000.00
RERE balance_sheet (annual, 2022-12-31) — Other Payable: 96668000.00
RERE balance_sheet (annual, 2022-12-31) — Other Properties: 70491000.00
RERE balance_sheet (annual, 2022-12-31) — Other Receivables: 855354000.00
RERE balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 782230000.00
RERE income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
RERE balance_sheet (annual, 2022-12-31) — Payables: 308014000.00
RERE balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 481998000.00
RERE cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
RERE balance_sheet (annual, 2022-12-31) — Prepaid Assets: 222263000.00
RERE income_statement (annual, 2022-12-31) — Pretax Income: -2573249000.00
RERE cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 2864000.00
RERE balance_sheet (annual, 2022-12-31) — Properties: 0.00
RERE cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 5870000.00
RERE cash_flow (annual, 2022-12-31) — Purchase Of Business: 29871000.00
RERE cash_flow (annual, 2022-12-31) — Purchase Of Investment: -878096000.00
RERE cash_flow (annual, 2022-12-31) — Purchase Of PPE: -61463000.00
RERE balance_sheet (annual, 2022-12-31) — Receivables: 970855000.00
RERE balance_sheet (annual, 2022-12-31) — Receivables Adjustments Allowances: -2358000.00
RERE income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 7596613000.00
RERE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 405408000.00
RERE cash_flow (annual, 2022-12-31) — Repayment Of Debt: -156970000.00
RERE cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -217920000.00
RERE income_statement (annual, 2022-12-31) — Research And Development: 227812000.00
RERE balance_sheet (annual, 2022-12-31) — Restricted Cash: 0.00
RERE balance_sheet (annual, 2022-12-31) — Retained Earnings: -9006884000.00
RERE cash_flow (annual, 2022-12-31) — Sale Of Business: 29871000.00
RERE cash_flow (annual, 2022-12-31) — Sale Of Investment: 394488000.00
RERE cash_flow (annual, 2022-12-31) — Sale Of PPE: 5517000.00
RERE income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 1536052000.00
RERE income_statement (annual, 2022-12-31) — Selling General And Administration: 1766473000.00
RERE balance_sheet (annual, 2022-12-31) — Share Issued: 149216125.00
RERE cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 185983000.00
RERE cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -156970000.00
RERE income_statement (annual, 2022-12-31) — Special Income Charges: -1819926000.00
RERE cash_flow (annual, 2022-12-31) — Stock Based Compensation: 174236000.00
RERE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3881672000.00
RERE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3337022000.00
RERE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -78984788.40
RERE income_statement (annual, 2022-12-31) — Tax Provision: -111783000.00
RERE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.04
RERE balance_sheet (annual, 2022-12-31) — Taxes Receivable: 99547000.00
RERE balance_sheet (annual, 2022-12-31) — Total Assets: 5048755000.00
RERE balance_sheet (annual, 2022-12-31) — Total Capitalization: 3881672000.00
RERE balance_sheet (annual, 2022-12-31) — Total Debt: 203932000.00
RERE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3881672000.00
RERE income_statement (annual, 2022-12-31) — Total Expenses: 10673155000.00
RERE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1167083000.00
RERE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1158577000.00
RERE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 144835000.00
RERE income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -2623657000.00
RERE balance_sheet (annual, 2022-12-31) — Total Tax Payable: 90407000.00
RERE income_statement (annual, 2022-12-31) — Total Unusual Items: -1819926000.00
RERE income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1819926000.00
RERE balance_sheet (annual, 2022-12-31) — Treasury Stock: 217920000.00
RERE cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 36432000.00
RERE balance_sheet (annual, 2022-12-31) — Working Capital: 2867930000.00
RERE income_statement (annual, 2023-12-31) — +Operating Expense: 2800250000.00
RERE income_statement (annual, 2023-12-31) — +Total Revenue: 12965782000.00
RERE balance_sheet (annual, 2023-12-31) — Accounts Payable: 532293000.00
RERE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 56813000.00
RERE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -199753000.00
RERE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 13268487000.00
RERE cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 45749000.00
RERE balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 336549000.00
RERE income_statement (annual, 2023-12-31) — Basic Average Shares: 245698235.00
RERE income_statement (annual, 2023-12-31) — Basic EPS: -0.63
RERE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1703626000.00
RERE balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 0.00
RERE cash_flow (annual, 2023-12-31) — Capital Expenditure: -85183000.00
RERE balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 56004000.00
RERE balance_sheet (annual, 2023-12-31) — Capital Stock: 921000.00
RERE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 1978696000.00
RERE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 2389243000.00
RERE cash_flow (annual, 2023-12-31) — Cash Dividends Paid: 0.00
RERE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 68703000.00
RERE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 172013000.00
RERE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 243898000.00
RERE cash_flow (annual, 2023-12-31) — Change In Account Payable: 458957000.00
RERE cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -75769000.00
RERE cash_flow (annual, 2023-12-31) — Change In Inventory: -629436000.00
RERE cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -5180000.00
RERE cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -48508000.00
RERE cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -119308000.00
RERE cash_flow (annual, 2023-12-31) — Change In Payable: 489385000.00
RERE cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 413616000.00
RERE cash_flow (annual, 2023-12-31) — Change In Receivables: 132735000.00
RERE cash_flow (annual, 2023-12-31) — Change In Working Capital: -256081000.00
RERE cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 93808000.00
RERE cash_flow (annual, 2023-12-31) — Changes In Cash: 484614000.00
RERE balance_sheet (annual, 2023-12-31) — Common Stock: 921000.00
RERE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3711461000.00
RERE cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
RERE cash_flow (annual, 2023-12-31) — Common Stock Payments: -160068000.00
RERE balance_sheet (annual, 2023-12-31) — Construction In Progress: 27522000.00
RERE income_statement (annual, 2023-12-31) — Cost Of Revenue: 10338870000.00
RERE balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 169709000.00
RERE balance_sheet (annual, 2023-12-31) — Current Assets: 4526719000.00
RERE balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 33509000.00
RERE balance_sheet (annual, 2023-12-31) — Current Debt: 349931000.00
RERE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 383440000.00
RERE balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 119715000.00
RERE balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 119715000.00
RERE balance_sheet (annual, 2023-12-31) — Current Liabilities: 1691465000.00
RERE balance_sheet (annual, 2023-12-31) — Current Provisions: 8159000.00
RERE cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 333731000.00
RERE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 333731000.00
RERE income_statement (annual, 2023-12-31) — Diluted Average Shares: 245698235.00
RERE income_statement (annual, 2023-12-31) — Diluted EPS: -0.63
RERE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -156250000.00
RERE balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 89592000.00
RERE balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Non Current: 0.00
RERE balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 78032000.00
RERE income_statement (annual, 2023-12-31) — EBIT: -141350000.00
RERE income_statement (annual, 2023-12-31) — EBITDA: 192381000.00
RERE income_statement (annual, 2023-12-31) — Earnings From Equity Interest Net Of Tax: -50374000.00
RERE cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 50374000.00
RERE cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 2456000.00
RERE cash_flow (annual, 2023-12-31) — End Cash Position: 2190696000.00
RERE cash_flow (annual, 2023-12-31) — Financing Cash Flow: 68703000.00
RERE cash_flow (annual, 2023-12-31) — Free Cash Flow: 158715000.00
RERE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
RERE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 5347000.00
RERE balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -16825000.00
RERE income_statement (annual, 2023-12-31) — General And Administrative Expense: 265981000.00
RERE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 270631000.00
RERE balance_sheet (annual, 2023-12-31) — Gross PPE: 347976000.00
RERE income_statement (annual, 2023-12-31) — Gross Profit: 2626912000.00
RERE income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
RERE income_statement (annual, 2023-12-31) — Interest Expense: 7056000.00
RERE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 7056000.00
RERE income_statement (annual, 2023-12-31) — Interest Income: 37875000.00
RERE income_statement (annual, 2023-12-31) — Interest Income Non Operating: 37875000.00
RERE cash_flow (annual, 2023-12-31) — Interest Paid Cff: 0.00
RERE cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 7056000.00
RERE balance_sheet (annual, 2023-12-31) — Inventory: 1017155000.00
RERE balance_sheet (annual, 2023-12-31) — Invested Capital: 4061392000.00
RERE cash_flow (annual, 2023-12-31) — Investing Cash Flow: 172013000.00
RERE balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 336549000.00